U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Malignant Glioma

MedGen UID:
1635459
•Concept ID:
C4684868
•
Neoplastic Process

Definition

Malignant glioma that does not respond to treatment. [from NCI]

Professional guidelines

PubMed

Treatment of Pediatric Low-Grade Gliomas.
Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM, Karajannis MA
Curr Neurol Neurosci Rep 2023 Apr;23(4):185-199. Epub 2023 Mar 7 doi: 10.1007/s11910-023-01257-3. PMID: 36881254Free PMC Article
Medicinal Plants for Glioblastoma Treatment.
Datta S, Luthra R, Bharadvaja N
Anticancer Agents Med Chem 2022;22(13):2367-2384. doi: 10.2174/1871520622666211221144739. PMID: 34939551
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Menyhárt O, Győrffy B
Cancer Metastasis Rev 2020 Mar;39(1):211-233. doi: 10.1007/s10555-020-09854-1. PMID: 31970590Free PMC Article

Recent clinical studies

Etiology

Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mastrangelo S, Migliorati R, Bertolini P, Colosimo C, Riccardi R
J Neurooncol 2013 Jul;113(3):513-8. Epub 2013 May 12 doi: 10.1007/s11060-013-1145-z. PMID: 23666235
Extended-schedule dose-dense temozolomide in refractory gliomas.
Berrocal A, Perez Segura P, Gil M, Balaña C, Garcia Lopez J, Yaya R, Rodríguez J, Reynes G, Gallego O, Iglesias L; GENOM Cooperative Group
J Neurooncol 2010 Feb;96(3):417-22. Epub 2009 Aug 8 doi: 10.1007/s11060-009-9980-7. PMID: 19669096Free PMC Article

Diagnosis

Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.
Hyman DM, Rizvi N, Natale R, Armstrong DK, Birrer M, Recht L, Dotan E, Makker V, Kaley T, Kuruvilla D, Gribbin M, McDevitt J, Lai DW, Dar M
Clin Cancer Res 2018 Jun 15;24(12):2749-2757. Epub 2018 Mar 20 doi: 10.1158/1078-0432.CCR-17-1775. PMID: 29559563Free PMC Article
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mastrangelo S, Migliorati R, Bertolini P, Colosimo C, Riccardi R
J Neurooncol 2013 Jul;113(3):513-8. Epub 2013 May 12 doi: 10.1007/s11060-013-1145-z. PMID: 23666235
New approaches for temozolomide therapy: use in newly diagnosed glioma.
Stupp R, Newlands E
Semin Oncol 2001 Aug;28(4 Suppl 13):19-23. doi: 10.1016/s0093-7754(01)90067-3. PMID: 11550135

Therapy

Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.
Hyman DM, Rizvi N, Natale R, Armstrong DK, Birrer M, Recht L, Dotan E, Makker V, Kaley T, Kuruvilla D, Gribbin M, McDevitt J, Lai DW, Dar M
Clin Cancer Res 2018 Jun 15;24(12):2749-2757. Epub 2018 Mar 20 doi: 10.1158/1078-0432.CCR-17-1775. PMID: 29559563Free PMC Article
Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.
Nagane M, Kobayashi K, Tanaka M, Tsuchiya K, Shishido-Hara Y, Shimizu S, Shiokawa Y
Int J Clin Oncol 2014 Feb;19(1):16-23. Epub 2013 Jan 26 doi: 10.1007/s10147-013-0517-x. PMID: 23354833
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mastrangelo S, Migliorati R, Bertolini P, Colosimo C, Riccardi R
J Neurooncol 2013 Jul;113(3):513-8. Epub 2013 May 12 doi: 10.1007/s11060-013-1145-z. PMID: 23666235
Extended-schedule dose-dense temozolomide in refractory gliomas.
Berrocal A, Perez Segura P, Gil M, Balaña C, Garcia Lopez J, Yaya R, Rodríguez J, Reynes G, Gallego O, Iglesias L; GENOM Cooperative Group
J Neurooncol 2010 Feb;96(3):417-22. Epub 2009 Aug 8 doi: 10.1007/s11060-009-9980-7. PMID: 19669096Free PMC Article
New approaches for temozolomide therapy: use in newly diagnosed glioma.
Stupp R, Newlands E
Semin Oncol 2001 Aug;28(4 Suppl 13):19-23. doi: 10.1016/s0093-7754(01)90067-3. PMID: 11550135

Prognosis

Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.
Nagane M, Kobayashi K, Tanaka M, Tsuchiya K, Shishido-Hara Y, Shimizu S, Shiokawa Y
Int J Clin Oncol 2014 Feb;19(1):16-23. Epub 2013 Jan 26 doi: 10.1007/s10147-013-0517-x. PMID: 23354833
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mastrangelo S, Migliorati R, Bertolini P, Colosimo C, Riccardi R
J Neurooncol 2013 Jul;113(3):513-8. Epub 2013 May 12 doi: 10.1007/s11060-013-1145-z. PMID: 23666235
New approaches for temozolomide therapy: use in newly diagnosed glioma.
Stupp R, Newlands E
Semin Oncol 2001 Aug;28(4 Suppl 13):19-23. doi: 10.1016/s0093-7754(01)90067-3. PMID: 11550135

Clinical prediction guides

Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.
Nagane M, Kobayashi K, Tanaka M, Tsuchiya K, Shishido-Hara Y, Shimizu S, Shiokawa Y
Int J Clin Oncol 2014 Feb;19(1):16-23. Epub 2013 Jan 26 doi: 10.1007/s10147-013-0517-x. PMID: 23354833
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Ruggiero A, Rizzo D, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mastrangelo S, Migliorati R, Bertolini P, Colosimo C, Riccardi R
J Neurooncol 2013 Jul;113(3):513-8. Epub 2013 May 12 doi: 10.1007/s11060-013-1145-z. PMID: 23666235
Phase I study of phenylacetate administered twice daily to patients with cancer.
Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE
Cancer 1995 Jun 15;75(12):2932-8. doi: 10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p. PMID: 7773944

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...